Cargando…
Traditional, complementary and integrative healthcare: global stakeholder perspective on WHO’s current and future strategy
As the ‘WHO Traditional Medicine Strategy: 2014–2023’ is entering its final phase, reflection is warranted on progress and the focus for a new strategy. We used WHO documentation to analyse progress across the objectives of the current strategy, adding the role of traditional, complementary and inte...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693890/ http://dx.doi.org/10.1136/bmjgh-2023-013150 |
_version_ | 1785153259601657856 |
---|---|
author | von Schoen-Angerer, Tido Manchanda, Raj Kumar Lloyd, Iva Wardle, Jon Szöke, Janka Benevides, Iracema Martinez, Natalia Sofia Aldana Tolo, Festus Nicolai, Ton Skaling-Klopstock, Cristal Parker, Tabatha Suswardany, Dwi Linna van Haselen, Robbert Liu, Jianping |
author_facet | von Schoen-Angerer, Tido Manchanda, Raj Kumar Lloyd, Iva Wardle, Jon Szöke, Janka Benevides, Iracema Martinez, Natalia Sofia Aldana Tolo, Festus Nicolai, Ton Skaling-Klopstock, Cristal Parker, Tabatha Suswardany, Dwi Linna van Haselen, Robbert Liu, Jianping |
author_sort | von Schoen-Angerer, Tido |
collection | PubMed |
description | As the ‘WHO Traditional Medicine Strategy: 2014–2023’ is entering its final phase, reflection is warranted on progress and the focus for a new strategy. We used WHO documentation to analyse progress across the objectives of the current strategy, adding the role of traditional, complementary and integrative healthcare (TCIH) to address specific diseases as a dimension absent in the current strategy. Our analysis concludes on five areas. First, TCIH research is increasing but is not commensurate with TCIH use. TCIH research needs prioritisation and increased funding in national research policies and programmes. Second, WHO guidance for training and practice provides useful minimum standards but regulation of TCIH practitioners also need to reflect the different nature of formal and informal practices. Third, there has been progress in the regulation of herbal medicines but TCIH products of other origin still need addressing. A risk-based regulatory approach for the full-range of TCIH products seems appropriate and WHO should provide guidance in this regard. Fourth, the potential of TCIH to help address specific diseases is often overlooked. The development of disease strategies would benefit from considering the evidence and inclusion of TCIH practices, as appropriate. Fifth, inclusion of TCIH in national health policies differs between countries, with some integrating TCIH practices and others seeking to restrict them. We encourage a positive framework in all countries that enshrines the role of TCIH in the achievement of universal health coverage. Finally, we encourage seeking the input of stakeholders in the development of the new WHO Traditional Medicine Strategy. |
format | Online Article Text |
id | pubmed-10693890 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-106938902023-12-04 Traditional, complementary and integrative healthcare: global stakeholder perspective on WHO’s current and future strategy von Schoen-Angerer, Tido Manchanda, Raj Kumar Lloyd, Iva Wardle, Jon Szöke, Janka Benevides, Iracema Martinez, Natalia Sofia Aldana Tolo, Festus Nicolai, Ton Skaling-Klopstock, Cristal Parker, Tabatha Suswardany, Dwi Linna van Haselen, Robbert Liu, Jianping BMJ Glob Health Analysis As the ‘WHO Traditional Medicine Strategy: 2014–2023’ is entering its final phase, reflection is warranted on progress and the focus for a new strategy. We used WHO documentation to analyse progress across the objectives of the current strategy, adding the role of traditional, complementary and integrative healthcare (TCIH) to address specific diseases as a dimension absent in the current strategy. Our analysis concludes on five areas. First, TCIH research is increasing but is not commensurate with TCIH use. TCIH research needs prioritisation and increased funding in national research policies and programmes. Second, WHO guidance for training and practice provides useful minimum standards but regulation of TCIH practitioners also need to reflect the different nature of formal and informal practices. Third, there has been progress in the regulation of herbal medicines but TCIH products of other origin still need addressing. A risk-based regulatory approach for the full-range of TCIH products seems appropriate and WHO should provide guidance in this regard. Fourth, the potential of TCIH to help address specific diseases is often overlooked. The development of disease strategies would benefit from considering the evidence and inclusion of TCIH practices, as appropriate. Fifth, inclusion of TCIH in national health policies differs between countries, with some integrating TCIH practices and others seeking to restrict them. We encourage a positive framework in all countries that enshrines the role of TCIH in the achievement of universal health coverage. Finally, we encourage seeking the input of stakeholders in the development of the new WHO Traditional Medicine Strategy. BMJ Publishing Group 2023-12-02 /pmc/articles/PMC10693890/ http://dx.doi.org/10.1136/bmjgh-2023-013150 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Analysis von Schoen-Angerer, Tido Manchanda, Raj Kumar Lloyd, Iva Wardle, Jon Szöke, Janka Benevides, Iracema Martinez, Natalia Sofia Aldana Tolo, Festus Nicolai, Ton Skaling-Klopstock, Cristal Parker, Tabatha Suswardany, Dwi Linna van Haselen, Robbert Liu, Jianping Traditional, complementary and integrative healthcare: global stakeholder perspective on WHO’s current and future strategy |
title | Traditional, complementary and integrative healthcare: global stakeholder perspective on WHO’s current and future strategy |
title_full | Traditional, complementary and integrative healthcare: global stakeholder perspective on WHO’s current and future strategy |
title_fullStr | Traditional, complementary and integrative healthcare: global stakeholder perspective on WHO’s current and future strategy |
title_full_unstemmed | Traditional, complementary and integrative healthcare: global stakeholder perspective on WHO’s current and future strategy |
title_short | Traditional, complementary and integrative healthcare: global stakeholder perspective on WHO’s current and future strategy |
title_sort | traditional, complementary and integrative healthcare: global stakeholder perspective on who’s current and future strategy |
topic | Analysis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693890/ http://dx.doi.org/10.1136/bmjgh-2023-013150 |
work_keys_str_mv | AT vonschoenangerertido traditionalcomplementaryandintegrativehealthcareglobalstakeholderperspectiveonwhoscurrentandfuturestrategy AT manchandarajkumar traditionalcomplementaryandintegrativehealthcareglobalstakeholderperspectiveonwhoscurrentandfuturestrategy AT lloydiva traditionalcomplementaryandintegrativehealthcareglobalstakeholderperspectiveonwhoscurrentandfuturestrategy AT wardlejon traditionalcomplementaryandintegrativehealthcareglobalstakeholderperspectiveonwhoscurrentandfuturestrategy AT szokejanka traditionalcomplementaryandintegrativehealthcareglobalstakeholderperspectiveonwhoscurrentandfuturestrategy AT benevidesiracema traditionalcomplementaryandintegrativehealthcareglobalstakeholderperspectiveonwhoscurrentandfuturestrategy AT martineznataliasofiaaldana traditionalcomplementaryandintegrativehealthcareglobalstakeholderperspectiveonwhoscurrentandfuturestrategy AT tolofestus traditionalcomplementaryandintegrativehealthcareglobalstakeholderperspectiveonwhoscurrentandfuturestrategy AT nicolaiton traditionalcomplementaryandintegrativehealthcareglobalstakeholderperspectiveonwhoscurrentandfuturestrategy AT skalingklopstockcristal traditionalcomplementaryandintegrativehealthcareglobalstakeholderperspectiveonwhoscurrentandfuturestrategy AT parkertabatha traditionalcomplementaryandintegrativehealthcareglobalstakeholderperspectiveonwhoscurrentandfuturestrategy AT suswardanydwilinna traditionalcomplementaryandintegrativehealthcareglobalstakeholderperspectiveonwhoscurrentandfuturestrategy AT vanhaselenrobbert traditionalcomplementaryandintegrativehealthcareglobalstakeholderperspectiveonwhoscurrentandfuturestrategy AT liujianping traditionalcomplementaryandintegrativehealthcareglobalstakeholderperspectiveonwhoscurrentandfuturestrategy |